Asan Multivessel Registry (ASAN MV)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Asan Medical Center
Sponsor:
Information provided by (Responsible Party):
Seung-Jung Park, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT02039752
First received: January 14, 2014
Last updated: July 22, 2014
Last verified: July 2014
  Purpose

The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.


Condition Intervention
Coronary Artery Disease
Other: Treatment

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Asan Medical Center Registry for Multivessel

Further study details as provided by Asan Medical Center:

Primary Outcome Measures:
  • composite event [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
    death, myocardial infarction, stroke, revascularization


Secondary Outcome Measures:
  • Death [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Myocardial Infarction [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Stroke [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Revascularization [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Angina symptom [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Bleeding [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Re-hospitalization [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
  • Stent thrombosis [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
    by ARC(Academic Research Consortium) category


Estimated Enrollment: 25000
Study Start Date: March 2014
Estimated Study Completion Date: June 2025
Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Multivessel
from 1995 to 2015
Other: Treatment
Other Names:
  • Medically
  • Surgically
  • Percutaneously

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with multivessel disease from 1995 to 2015 in Asan Medical Center

Criteria

Inclusion Criteria:

  • Patients with multivessel disease from 1995 to 2015 in Asan Medical Center
  • Age 19 and more

Exclusion Criteria:

  • For prospective cohort not agreeing to participate with written informed consent form
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02039752

Locations
Korea, Republic of
Asan Medical Center Recruiting
Seoul, Korea, Republic of
Contact: Seung-Jung Park, MD,PhD       sjpark@amc.seoul.kr   
Contact: Jung-Hee Ham       cvcrc5@amc.seoul.kr   
Principal Investigator: Seung-Jung Park, MD,PhD         
Sponsors and Collaborators
Seung-Jung Park
  More Information

No publications provided

Responsible Party: Seung-Jung Park, MD,PhD, Asan Medical Center
ClinicalTrials.gov Identifier: NCT02039752     History of Changes
Other Study ID Numbers: AMCCV2013-15
Study First Received: January 14, 2014
Last Updated: July 22, 2014
Health Authority: Korea: Institutional Review Board

Keywords provided by Asan Medical Center:
Multivessel

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 01, 2014